Cognitive impairment in multiple sclerosis: diagnosis and monitoring

Autor: Angela Vidal-Jordana, Ricardo C Ginestal-López, Virginia Meca-Lallana, Francisco Pérez-Miralles, Joan Carreres-Polo, Francisco Gascón-Giménez, Nieves Téllez-Lara, Yolanda Higueras, Jesús Romero-Imbroda, Sara Eichau-Madueño
Přispěvatelé: Institut Català de la Salut, [Meca-Lallana V] Unidad de Enfermedades Desmielinizantes, Servicio de Neurología, Hospital Universitario de La Princesa, Madrid, Spain. [Gascón-Giménez F] Unidad de Esclerosis Múltiple, Servicio de Neurología, Hospital Clínico Universitario, Valencia, Spain. [Ginestal-López RC] Servicio de Neurología, Hospital Clínico San Carlos, Madrid, Spain. [Higueras Y] Instituto de Investigación Sanitaria del Gregorio Marañón, Hospital Gregorio Marañón, Madrid, Spain. [Téllez-Lara N] Servicio de Neurología, Hospital Clínico Universitario, Valladolid, Spain. [Carreres-Polo J] Servicio de Radiología, Hospital Universitari i Politècnic La Fe de Valencia, Valencia, Spain. [Vidal-Jordana Á] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Esclerosi múltiple - Complicacions
medicine.medical_specialty
Neurology
Otros calificadores::/diagnóstico [Otros calificadores]
Dermatology
Cognitive dysfunction
Multiple sclerosis
Neurophysiological monitoring
Neuropsychological tests
Multiple sclerosis
Otros calificadores::Otros calificadores::/complicaciones [Otros calificadores]
Physical medicine and rehabilitation
Quality of life (healthcare)
Cognitive dysfunction
Multidisciplinary approach
Neuropsychology
Other subheadings::/diagnosis [Other subheadings]
Medicine
Humans
Neuropsychological assessment
Cognitive rehabilitation therapy
Tests neuropsicològics
Cognitive evaluation theory
medicine.diagnostic_test
business.industry
Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases
CNS::Multiple Sclerosis [DISEASES]
Cognition
General Medicine
Psychiatry and Mental health
Neuropsychological tests
Mental Disorders::Neurocognitive Disorders::Cognition Disorders::Cognitive Dysfunction [PSYCHIATRY AND PSYCHOLOGY]
enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple [ENFERMEDADES]
Quality of Life
Original Article
Neurology (clinical)
Neurophysiological monitoring
business
Trastorns de la cognició - Diagnòstic
trastornos mentales::trastornos neurocognitivos::trastornos cognitivos::disfunción cognitiva [PSIQUIATRÍA Y PSICOLOGÍA]
Other subheadings::Other subheadings::/complications [Other subheadings]
Zdroj: Scientia
NEUROLOGICAL SCIENCES
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Neurological Sciences
ISSN: 1590-1874
Popis: Introduction Cognitive impairment (CI) has a prevalence of 45–70% in people with multiple sclerosis (MS), producing a negative impact on their quality of life, personal life, and work. Early detection of CI has become an important aspect to be considered for an adequate follow-up, to optimize social adaptation and to implement specific cognitive rehabilitation strategies. The aim of this work is to propose a suitable cognitive evaluation of patients with MS based on available and efficient tools for diagnosis and monitoring purposes well supported by literature review and clinical experience. Methods A multidisciplinary panel of professionals from the field of neurology, neuropsychology, and neuroimaging performed a literature review of the topic of cognitive impairment assessment. This was combined and completed with their clinical experience to produce a set of recommendations. Results Some limitations to cognitive evaluation are described: shortage of time and resources during the neurology consultation, scarceness or absence of specialized professionals’ availability, importance of tests adaptation, and doubts about its use to define therapeutic efficiency. We recommend a baseline and annual screening evaluation, and we suggest a baseline and periodic neuropsychological assessment. The latter ought to change to a recommendation with the presence of either positive screening test, or subjective to cognitive complaints, screening-test results and patient or family report mismatch, or in specific social/work situations. Conclusions Cognitive evaluation should be performed on all patients diagnosed with MS and throughout follow-up. It is necessary to support the creation of multidisciplinary MS teams to optimize the evaluation and follow-up of MS patients.
Databáze: OpenAIRE
Externí odkaz: